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in achalasia: Linking new technology
to treatment outcomeAchalasia, meaning “failure to relax” in Greek, is the most
investigated primary esophageal motility disorder involving
the smooth muscle of the esophageal body and lower
esophageal sphincter (LES). Recent decades have witnessed
a great stride toward better understanding and manage-
ment of this old but rare disease. However, the exact eti-
ology and pathogenesis of achalasia remain elusive. Lines of
evidence show that an initial insult, such as HSV-1 infec-
tion, to the esophagus and esophagogastric junction might
trigger an inflammatory process in the myenteric plexus,
which may be followed by autoimmune responses, resulting
in neurodegeneration with loss of inhibitory neurons. The
histopathology of achalasia further demonstrates degener-
ation of ganglion cells, especially inhibitory neurons, in the
myenteric plexus of the esophageal body and LES. It has
been proposed that dysfunction of the nitrergic pathway
might cause LES hypertension and impaired relaxation in
achalasia [1].
With progressive dysphagia to both solid and liquid food,
achalasia affects patients not only physically but also psy-
chologically. Chest pain, heartburn, regurgitation and
weight loss may also occur. Abnormal food intake is usually
accompanied by behavior accommodation such as slow
eating, water/soup drinking after meals, stereotactic
movements and social avoidance. Endoscopy is commonly
the initial modality used to search for the causes of
dysphagia. However, the esophagus may show minimal
change or appear to be completely normal. Therefore, the
diagnosis of achalasia is usually delayed until typical find-
ings of the “bird-beak” appearance of the LES and marked
dilated esophagus are shown on barium esophagogram.
Currently, esophageal manometry, which demonstrates the
characteristic aperistalsis, LES hypertension and poor LES
relaxation, remains the gold standard in the diagnosis of
achalasia. Recently, multichannel intraluminal impedance
(MII) monitoring has gained popularity not only as a reflux
detection tool but also as a novel method for examininghttp://dx.doi.org/10.1016/j.aidm.2014.04.001
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Esophageal impedance monitoring measures the difference
in impedance (resistance) to alternating electrical currents
generated between pairs of electrodes mounted on a non-
conductive catheter. Luminal content with high ionic con-
centration has low impedance and air has high impedance.
Therefore, the impedance level drops when a liquid bolus
passes and increases when air passes. The direction of
movement of intra-esophageal material can thus be iden-
tified as antegrade or retrograde. When MII and esophageal
manometry are integrated into the same diagnostic devi-
cedcombined “MII-EM”dthe new technique not only as-
sesses the peristaltic patterns of the esophagus but also
better characterizes the actual bolus movement. Several
different features of bolus transport can be obtained with
combined MII-EM, including patterns/parameters of bolus
transport and swallow-related events. Taking advantage of
these functions, MII-EM provides better evaluation of global
esophageal function than conventional standard esopha-
geal manometry, which mainly assesses pressure changes in
the esophageal body and LES [2].
In this issue of the Journal, Lei et al. [3] report the first
observational study of combined MII-EM in Taiwanese pa-
tients with achalasia. Although the case number was rela-
tively small, the authors confirmed that patients with
achalasia were characterized by poor esophageal contrac-
tion and absent esophageal bolus clearance. They also
clearly demonstrated a low baseline impedance level in the
distal esophagus and air entrapment in the proximal
esophagus in all achalasia patients. Since intraluminal
impedance is inversely related to the electrical conduc-
tivity of the luminal contents and the cross-sectional area,
an extremely low impedance level was invariably found in
the markedly dilated and fluid-accumulated esophagus.
Such findings of low baseline impedance level and air
trapping were consistent with several previous studies and
suggest that the utility of combined MII-EM in thean and The Digestive Endoscopy Society of Taiwan. Published by
34 Editorialevaluation of esophageal motility in achalasia patients may
be limited [4e6]. A retrospective review of 73 MII-EM
tracings from patients with achalasia showed that most
patients have elevated LES residual pressure, normal LES
pressure, and low baseline impedance. Nonetheless, the
authors suggested that low impedance values identified
chronic fluid retention in the lower esophagus and help to
confirm the diagnosis [7]. In another retrospective analysis
comparing MII-EM tracings from patients with achalasia and
scleroderma, Mainie et al. confirmed that combined MII-EM
could characterize the difference in segmental bolus stasis
in these two groups of patients by detecting impaired bolus
transit [8]. Both studies highlight the clinical value of MII-
EM in the evaluation of achalasia. Although treatment
outcomes were not assessed by Lei et al. [3], another
important finding was that low baseline impedance levels
and incomplete bolus transit were still noted in both pa-
tients who had undergone Heller myotomy. At present,
management of primary achalasia focuses on the disruption
or weakening of the LES to lower LES pressure. Treatment
options include pharmacotherapy, botulinum toxin injec-
tion, endoscopic pneumatic dilation and surgical myotomy
of the LES, which has been extensively reviewed elsewhere
[9]. Among them, endoscopic pneumatic dilation and
myotomy have been proposed as effective first-line thera-
peutic modalities for achalasia, with similar efficacy [10].
However, both interventions for achalasia mainly disrupt
the LES without affecting the esophageal body, and
whether or not they have beneficial effects on the regain-
ing of esophageal function remains widely debated. Some
restoration in peristalsis as well as improved bolus clear-
ance after Heller myotomy for achalasia has been described
by Tatum et al. [11]. More studies are needed to clarify this
important issue.
The recent introduction of high-resolution manometry
(HRM), assembled with 36 solid-state sensors at much
shorter intervals (1 cm), provides a more convenient and
comprehensive evaluation of esophageal motor function.
Moreover, according to the updated Chicago classification
criteria of esophageal motility disorders, achalasia can be
further categorized with HRM into three subtypes: acha-
lasia with minimal esophageal pressurization (type I,
classic), achalasia with esophageal compression (type II),
and achalasia with spasm (type III) [12]. These subtypes
are closely related to the treatment outcomes of medical
or surgical therapies [13]. Although the impedance tech-
nique alone seems to be less suitable for the clinical
evaluation of achalasia, combined HRM and impedance
(HRIM) has been found to have excellent agreement with
timed barium esophagogram for assessing bolus retention
at 5 minutes, and has been suggested as a single test to
assess bolus retention and motor function in the manage-
ment of achalasia [14]. A recent study further showed that
the addition of automated integrated analysis of imped-
ance and pressure signals was more sensitive in detecting
subtle abnormalities in esophageal function in patients
with non-obstructive dysphagia and normal manometry
compared with conventional pressure-impedance assess-
ment [15].
A vast amount of knowledge on the basic and clinical
aspects of primary achalasia, mostly from observations of
human and animal mutant models, has accumulated inrecent decades. Since achalasia is a chronic and progressive
disease, early diagnosis and intervention before the clinical
onset of esophageal dysmotility to ameliorate the deteri-
oration in esophageal function is the goal of future
research. Although combined MII-EM seems to add little
further information for the management of achalasia, it
remains a useful tool for simultaneously assessing bolus
transit and associated muscular peristaltic patterns in many
other esophageal motility disorders. With advances in
technology, many novel techniques have been developed
and applied in the diagnosis and evaluation of various
esophageal motility disorders. Nonetheless, several tech-
nical aspects may still need to be refined and standardized,
such as study algorithms, test substances (volume, viscos-
ity) and body position (supine, upright). In the future, more
outcome studies to test the feasibility and predictability of
these new techniques are warranted before they can be
applied in our daily practice.
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